Monday 19 October 2026
Export PFSA’s income statement to Excel — free account
PROFUSA, Inc.
PFSA Healthcare Medical Devices
PROFUSA, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $100,000.00. In the quarter to June 2026, EPS grew 98.3%, free cash flow fell 359.3% and total debt fell 89.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
0.93
0.14
−13.08%
Follow PFSA
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
167.48% | 49.12% | 172.08% | 173.14% | |
| (502.86%) | (1,046.23%) | (2,569.79%) | (2,860.47%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
169.40% | 193.78% | 128.99% | 157.73% | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(2,704.05) | (5,369.41) | (1,133.14) | (366.66) | |
Free Cash Flow |
(11.36) | (18.26) | (19.15) | (21.27) | |
Capital Expenditures |
— | (2.01) | (0.86) | (0.94) | |
| Other line items | |||||
Cash ROIC |
103.95% | 165.17% | 83.20% | 100.05% | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
(3.68) | (5.44) | (7.50) | (6.03) | |
Operating CF/Net income |
0.35 | 0.45 | 0.50 | 0.47 | |
Depreciation/Fixed assets |
— | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
— | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(2,704.05) | (4,778.82) | (1,082.07) | (350.52) | |
Capex per Share |
0.00 | (590.59) | (51.07) | (16.14) | |
Capex to Sales |
— | 0.00 | 0.00 | 0.00 |
Columns are period end dates